NO20092638L - Angiotensin II-reseptorantagonister - Google Patents

Angiotensin II-reseptorantagonister

Info

Publication number: NO20092638L
Authority: NO; Norway
Prior art keywords: alkyl; angiotensin; hydrogen; receptor antagonists; cr3r4
Prior art date: 2006-12-13

Application number

NO20092638A

Other languages

English (en)

Norwegian (no)

Inventor

Nicoletta Almirante

Iyassu K Sebhat

Michael Man-Chu Lo

Ravi P Narugund

Amjad Ali

Chris Franklin

Laura Storoni

Silvia Stefanini

Original Assignee

Nicox Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-13

Filing date

2009-07-10

Publication date

2009-09-11

2009-07-10 Application filed by Nicox Sa filed Critical Nicox Sa

2009-09-11 Publication of NO20092638L publication Critical patent/NO20092638L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20092638A 2006-12-13 2009-07-10 Angiotensin II-reseptorantagonister NO20092638L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US87463006P	2006-12-13	2006-12-13
PCT/US2007/025233 WO2008076247A2 (en)	2006-12-13	2007-12-11	Nitroderivatives as angiotensin ii receptor antagonists

Publications (1)

Publication Number	Publication Date
NO20092638L true NO20092638L (no)	2009-09-11

Family

ID=39536882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20092638A NO20092638L (no)	2006-12-13	2009-07-10	Angiotensin II-reseptorantagonister

Country Status (18)

Country	Link
US (2)	US7880014B2 (zh)
EP (1)	EP2121665B1 (zh)
JP (1)	JP2010513274A (zh)
KR (1)	KR20090103916A (zh)
CN (1)	CN101547918A (zh)
AR (1)	AR064306A1 (zh)
AU (1)	AU2007334522B2 (zh)
CA (1)	CA2671673A1 (zh)
CL (1)	CL2007003613A1 (zh)
DO (1)	DOP2009000139A (zh)
EA (1)	EA200900808A1 (zh)
MX (1)	MX2009006210A (zh)
NO (1)	NO20092638L (zh)
PE (1)	PE20081382A1 (zh)
TN (1)	TN2009000236A1 (zh)
TW (1)	TW200831079A (zh)
WO (2)	WO2008076247A2 (zh)
ZA (1)	ZA200904479B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200831079A (en) *	2006-12-13	2008-08-01	Merck & Co Inc	Angiotensin II receptor antagonists
AR069340A1 (es) *	2007-11-26	2010-01-13	Merck & Co Inc	Antagonistas del receptor de angiotensina ii
US20110077279A1 (en) *	2008-06-09	2011-03-31	Nicoletta Almirante	Angiotensin ii receptor antagonists
AR073259A1 (es) *	2008-07-29	2010-10-28	Merck & Co Inc	Derivados de furosemida utiles como diureticos
JP2012511002A (ja)	2008-12-05	2012-05-17	メルク・シャープ・エンド・ドーム・コーポレイション	アンジオテンシンｉｉ受容体アンタゴニストとしてのニトロオキシ誘導体
RU2406435C1 (ru) *	2009-09-10	2010-12-20	Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко Федерального агентства по здравоохранению и социальному развитию"	Фармакологическая коррекция повышенного симпатического тонуса при назначении антагонистов кальция у больных с сочетанием артериальной гипертензии и бронхиальной астмы
JO3350B1 (ar)	2011-03-07	2019-03-13	Merck Sharp & Dohme	مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
CN105218527B (zh) *	2015-10-10	2018-04-24	江苏宝众宝达药业有限公司	一种exp-3174的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5138069A (en) *	1986-07-11	1992-08-11	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking imidazoles
IT1243367B (it)	1990-07-26	1994-06-10	Italfarmaco Spa	Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
IT1295694B1 (it) *	1996-11-14	1999-05-27	Nicox Sa	Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311924B1 (it)	1999-04-13	2002-03-20	Nicox Sa	Composti farmaceutici.
IT1311923B1 (it)	1999-04-13	2002-03-20	Nicox Sa	Composti farmaceutici.
IT1314184B1 (it)	1999-08-12	2002-12-06	Nicox Sa	Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
EP1603933A2 (en) *	2003-03-13	2005-12-14	Nitromed, Inc.	Nitrosated and nitrosylated compounds, compositions and methods of use
WO2005011646A2 (en) *	2003-07-31	2005-02-10	Nicox S.A.	Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
CA2536975A1 (en) *	2003-08-28	2005-03-17	Nitromed, Inc.	Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
AU2005206227A1 (en)	2004-01-27	2005-08-04	Merck Frosst Company	Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
WO2006079610A1 (en)	2005-01-31	2006-08-03	Nicox S.A.	Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases
US7396829B2 (en) *	2005-02-24	2008-07-08	Nitromed, Inc.	Nitric oxide enhancing diuretic compounds, compositions and methods of use
US20070032533A1 (en) *	2005-08-08	2007-02-08	Nitromed, Inc.	Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use
WO2008076245A2 (en) *	2006-12-13	2008-06-26	Merck & Co., Inc.	Nitroderivatives as angiotensin ii receptor antagonists
TW200831079A (en) *	2006-12-13	2008-08-01	Merck & Co Inc	Angiotensin II receptor antagonists
AR069340A1 (es) *	2007-11-26	2010-01-13	Merck & Co Inc	Antagonistas del receptor de angiotensina ii

2007
- 2007-12-07 TW TW096146849A patent/TW200831079A/zh unknown
- 2007-12-11 US US12/000,247 patent/US7880014B2/en not_active Expired - Fee Related
- 2007-12-11 WO PCT/US2007/025233 patent/WO2008076247A2/en not_active Ceased
- 2007-12-11 ZA ZA200904479A patent/ZA200904479B/xx unknown
- 2007-12-11 CN CNA2007800451998A patent/CN101547918A/zh active Pending
- 2007-12-11 EA EA200900808A patent/EA200900808A1/ru unknown
- 2007-12-11 US US12/516,482 patent/US20100152259A1/en not_active Abandoned
- 2007-12-11 AU AU2007334522A patent/AU2007334522B2/en not_active Ceased
- 2007-12-11 JP JP2009541327A patent/JP2010513274A/ja active Pending
- 2007-12-11 WO PCT/US2007/025232 patent/WO2008076246A2/en not_active Ceased
- 2007-12-11 KR KR1020097014549A patent/KR20090103916A/ko not_active Withdrawn
- 2007-12-11 MX MX2009006210A patent/MX2009006210A/es not_active Application Discontinuation
- 2007-12-11 CA CA002671673A patent/CA2671673A1/en not_active Abandoned
- 2007-12-11 EP EP07862716.3A patent/EP2121665B1/en active Active
- 2007-12-12 CL CL200703613A patent/CL2007003613A1/es unknown
- 2007-12-12 AR ARP070105570A patent/AR064306A1/es unknown
- 2007-12-12 PE PE2007001778A patent/PE20081382A1/es not_active Application Discontinuation
2009
- 2009-06-08 TN TNP2009000236A patent/TN2009000236A1/fr unknown
- 2009-06-12 DO DO2009000139A patent/DOP2009000139A/es unknown
- 2009-07-10 NO NO20092638A patent/NO20092638L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TN2009000236A1 (en)	2010-10-18
US7880014B2 (en)	2011-02-01
PE20081382A1 (es)	2008-09-18
EA200900808A1 (ru)	2009-12-30
CL2007003613A1 (es)	2008-07-11
WO2008076247A3 (en)	2009-01-15
EP2121665B1 (en)	2014-01-22
WO2008076246A2 (en)	2008-06-26
WO2008076247A2 (en)	2008-06-26
AU2007334522A1 (en)	2008-06-26
KR20090103916A (ko)	2009-10-01
JP2010513274A (ja)	2010-04-30
MX2009006210A (es)	2009-07-22
US20100152259A1 (en)	2010-06-17
AR064306A1 (es)	2009-03-25
DOP2009000139A (es)	2009-08-31
CN101547918A (zh)	2009-09-30
CA2671673A1 (en)	2008-06-26
EP2121665A2 (en)	2009-11-25
US20080194660A1 (en)	2008-08-14
ZA200904479B (en)	2010-09-29
AU2007334522B2 (en)	2012-03-15
WO2008076246A3 (en)	2009-01-15
TW200831079A (en)	2008-08-01

Publication	Publication Date	Title
NO20092638L (no)	2009-09-11	Angiotensin II-reseptorantagonister
NO20045120L (no)	2004-12-07	Triazolderivater som takykininreseptorantagonister
NO20076060L (no)	2007-12-28	Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister
NO20091551L (no)	2009-07-15	Derivater av 4-(2-amino-1-hydroksyetyl)fenyl som agonister for betta-2 adrenergisk reseptor
NO341631B1 (no)	2017-12-11	Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger
NO20073663L (no)	2007-09-03	Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20070173L (no)	2007-01-22	Nye forbindelser
WO2005080384A3 (en)	2006-09-28	Benzimidazole derivative and use as aii receptor antagonist
NO20074447L (no)	2007-10-18	Sykloheksylamider som dopamin D3, D2 og 5HT1A-antagonister
NO20083520L (no)	2008-09-11	Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser
NO20075809L (no)	2007-12-27	DNA-PK inhibitorer
WO2007095174A3 (en)	2007-12-13	Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
NO20073729L (no)	2007-08-08	Heterocykliske forbindelser som CCR2B-antagonister
NO20063501L (no)	2006-09-28	Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese
EP1076055A1 (en)	2001-02-14	1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
EA200870517A1 (ru)	2009-04-28	Новые антагонисты мсн-рецепторов
NO20054669L (no)	2005-11-14	Substituerte kinobenzoxazinanaloger
EP1640369A4 (en)	2007-10-31	THIAZOLIMINE COMPOUND AND OXAZOLIMINE COMPOUND
WO2009070241A3 (en)	2009-11-12	Angiotensin ii receptor antagonists
NO20080165L (no)	2008-03-14	Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister
NO20061584L (no)	2006-06-06	Substituerte 2-karbonylamino-6-piperidinaminopyridiner og substituerte 1-karbonylamino-3-piperidinaminobenzener som 5-HT1F agonister
NO20053561L (no)	2005-10-28	Mettede kinoksalinderivater og deres anvendelse som metabotrofe og glutamatreseptorligander
BRPI0510335A (pt)	2007-10-23	composto heterocìclico
NO20084698L (no)	2008-11-07	Metode for fremstilling av indazolyl-ureaer som inhiberer vanilloidreseptor subtype 1(VR1)
WO2008133344A3 (en)	2009-11-12	Piperidine derivative and use thereof

Legal Events

Date	Code	Title	Description
2010-08-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application
2010-09-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application